Search | Médecins Sans Frontières Access Campaign

118 results found

Press release |

03 February 2009

Kala Azar: Patients lack adequate diagnosis and drugs

Tags Intellectual property and tradeResearch and developmentTropical & neglected diseases visceral leishmaniasis (kala azar) India

Press release |

23 February 2009

MSF and DNDi call for scale-up of R&D for neglected diseases

Tags Research and developmentTropical & neglected diseases sleeping sicknessvisceral leishmaniasis (kala azar) DNDi

Press release |

12 June 2009

AMC - A New Deal To Boost Production Of Life-Saving Vaccines: What The Doctor Ordered?

Tags Research and developmentVaccines pneumococcal disease vaccines Gavi, the Vaccine Alliance

Press release |

10 May 2010

Global Vaccine Drive Facing Acute Crisis

Tags Vaccines pneumococcal disease vaccines Gavi, the Vaccine AllianceOxfamWorld Health Organization

Press release |

03 December 2011

At African AIDS Conference, MSF Calls For Increased Funding for HIV Treatment

Tags HIV/AIDSIntellectual property and tradeTropical & neglected diseasesTuberculosis co-infectionHIV/AIDSmeningitistuberculosisvisceral leishmaniasis (kala azar) antiretroviral medicines ICASAWorld AIDS Day

In Kacheliba, MSF offers a free treatment for patients affected by visceral leishmaniasis, commonly known as Kala-Azar. This disease, which can be fatal if not treated, is transmitted by sand flies

Press release |

08 December 2011

East African HIV programmes must wake up to visceral leishmaniasis

Tags HIV/AIDSTropical & neglected diseases co-infectionHIV/AIDSvisceral leishmaniasis (kala azar) ICASADNDi EthiopiaKenyaSudan

Kala Azar in Bihar, India. Sadar Hospital, Vaishali District. In partnership with the State Health Society-Bihar, MSF has managed a Kala Azar diagnosis and treatment project in Vaishali District since 2007, and has treated more than 10,000 patients free-of-charge within government facilities.

Press release |

14 March 2012

MSF Calls for a Spotlight on Kala Azar

Tags Tropical & neglected diseases co-infectionvisceral leishmaniasis (kala azar) South AfricaIndia

Press release |

11 June 2012

Neglected Tropical Diseases: New MSF Report Highlights How to Break the Cycle of Neglect

Tags Intellectual property and tradeResearch and developmentTropical & neglected diseases sleeping sicknessvisceral leishmaniasis (kala azar)neglected diseases research and development (R&D)

Press release |

08 November 2012

Research results show need to tailor vaccines to improve their impact

Tags Vaccines pneumococcal diseaserotavirus vaccines GlaxoSmithKlineMerck Niger

Press release |

22 November 2012

International Medical Conference to Assess Progress and Shortcomings of Global Health Revolution for Neglected Patients

Tags HIV/AIDSIntellectual property and tradeMalariaMalnutritionResearch and developmentTropical & neglected diseasesTuberculosisVaccines drug-resistant TBHIV/AIDStuberculosisvisceral leishmaniasis (kala azar) DNDi

Press release |

05 December 2012

MSF Urges GAVI to Extend Vaccine Prices to Humanitarian Actors to Help Close Gap of Unvaccinated Children

Tags Intellectual property and tradeVaccines pneumococcal disease vaccines Gavi, the Vaccine AllianceGlaxoSmithKline Kenya

Press release |

12 December 2012

Millions of Patients Still Waiting for Medical “Breakthroughs” Against Neglected Diseases

Tags HIV/AIDSIntellectual property and tradeResearch and developmentTropical & neglected diseasesTuberculosisVaccines neglected diseasessleeping sicknessvisceral leishmaniasis (kala azar) research and development (R&D)

Press release |

23 April 2013

Global vaccines community must bring price of new vaccines down

Tags Intellectual property and tradeVaccines pneumococcal diseaserotavirus vaccines Gavi, the Vaccine Alliance

Sudanese refugees began streaming across the border into South Sudan in June 2011 when conflict erupted between the Khartoum government and the rebels of the Sudan People’s Liberation Movement-North (SPLM-N) in Sudan’s South Kordofan State. Photograph by Yann Libessart

Press release |

08 August 2013

Global vaccination community turns its back on getting new vaccines to refugee children

Tags Vaccines pneumococcal disease vaccines Gavi, the Vaccine Alliance South Sudan

MSF held the first of three rounds of a mass vaccination campaign in Adjumani district of northern Uganda to protect children from deadly respiratory infections, July 2014.

Press release |

19 January 2015

MSF calls on GSK and Pfizer to slash pneumo vaccine price to $5 per child for poor countries ahead of donor meeting

Tags Vaccines pneumococcal disease Gavi, the Vaccine AllianceGlaxoSmithKlinePfizer

DESCRIPTION:MSF stunt in Berlin outside the venue of the Gavi replenishment meeting, demanding GSK and Pfizer to reduce their price for the pneumococcal vaccine to $5 per child. The stunt involves world leaders spinning a wheel of chance in which - when it comes to the PCV vaccine - pharma almost always wins.

Press release |

20 January 2015

MSF response to GSK and Pfizer’s statement on the pneumonia vaccine (pneumococcal conjugate vaccine, PCV)

Tags Vaccines pneumococcal disease Gavi, the Vaccine AllianceGlaxoSmithKlinePfizer

2013 marked the first time that PCV is being used in South Sudan and one of the first vaccines to be implemented in compliance with the new WHO emergency vaccination recommendations.

Press release |

26 January 2015

MSF responds to Pfizer announcement of pneumococcal vaccine price reduction

Tags Vaccines pneumococcal disease vaccines Gavi, the Vaccine AllianceGlaxoSmithKlinePfizer

Campaign asking Pfizer & GSK to drop the prices of pneumonia vaccines down to 5$/child

Press release |

23 April 2015

MSF kicks off global ████ to reduce the price of ████ to $5 in developing countries

Tags Vaccines pneumococcal disease vaccines access to medicines GlaxoSmithKlinePfizer

Vax_CAR_Measles_MagaliDeppen_2015_MSF152051

Press release |

13 January 2016

Central African Republic (CAR): MSF launches vaccination campaign of unprecedented scale

Tags Vaccines pneumococcal disease pneumococcal conjugate vaccinevaccines Pfizer Central African Republic

In New York, on Word Pneumonia Day 2015 (Nov 12), MSF volunteers attempted to deliver more than $17 million of fake cash - the equivalent of one day of profits from the pneumonia vaccines for Pfizer globally - to Pfizer's CEO Ian Read. The same day, MSF launched a global petition to ask Pfizer and GlaxoSmithKline (GSK) to reduce the price of the pneumococcal vaccine to $5 dollars per child (for all three doses) in developing countries. Photograph by Edwin Torres

Press release |

11 November 2016

Breaking news: Pfizer drops the price of the pneumonia vaccine for humanitarian organizations

Tags Vaccines pneumococcal disease pneumococcal conjugate vaccinevaccines Pfizer

Date

Primary topics

Types of content

Products

Diseases

General Terms

Geography

Campaigns

Institutions & Events

Report series

Miscellaneous

Kala Azar: Patients lack adequate diagnosis and drugs

MSF and DNDi call for scale-up of R&D for neglected diseases

AMC - A New Deal To Boost Production Of Life-Saving Vaccines: What The Doctor Ordered?

Global Vaccine Drive Facing Acute Crisis

At African AIDS Conference, MSF Calls For Increased Funding for HIV Treatment

East African HIV programmes must wake up to visceral leishmaniasis

MSF Calls for a Spotlight on Kala Azar

Neglected Tropical Diseases: New MSF Report Highlights How to Break the Cycle of Neglect

Research results show need to tailor vaccines to improve their impact

International Medical Conference to Assess Progress and Shortcomings of Global Health Revolution for Neglected Patients

MSF Urges GAVI to Extend Vaccine Prices to Humanitarian Actors to Help Close Gap of Unvaccinated Children

Millions of Patients Still Waiting for Medical “Breakthroughs” Against Neglected Diseases

Global vaccines community must bring price of new vaccines down

Global vaccination community turns its back on getting new vaccines to refugee children

MSF calls on GSK and Pfizer to slash pneumo vaccine price to $5 per child for poor countries ahead of donor meeting

MSF response to GSK and Pfizer’s statement on the pneumonia vaccine (pneumococcal conjugate vaccine, PCV)

MSF responds to Pfizer announcement of pneumococcal vaccine price reduction

MSF kicks off global ████ to reduce the price of ████ to $5 in developing countries

Central African Republic (CAR): MSF launches vaccination campaign of unprecedented scale

Breaking news: Pfizer drops the price of the pneumonia vaccine for humanitarian organizations